Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
139 hedge funds and large institutions have $231M invested in Spectrum Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 22 closing their positions.
34% more call options, than puts
Call options by funds: $321K | Put options by funds: $239K
17% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 41
3% less funds holding
Funds holding: 144 → 139 (-5)
12% less capital invested
Capital invested by funds: $264M → $231M (-$32.9M)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.64M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.01M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.83M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$759K |
| 5 |
Millennium Management
New York
|
+$726K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.9M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.33M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.35M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.04M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.85M |
SPPI Hedge Fund Activity: Q4 2016 in Review
139 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2016, worth a combined $231M — down 12% from $264M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of SPPI and 19 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 48 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.64M. The largest seller was Fidelity Investments, cutting an estimated $11.9M.
- 139 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2016, down from 144 in Q3 2016.
- Funds reported $231M of Spectrum Pharmaceuticals Inc stock for Q4 2016, down 12% quarter-over-quarter.
- 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2016 and 22 closed out, a net change of -3 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $4.64M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2016 was Fidelity Investments, an estimated $11.9M sold.
Based on aggregated 13F filings for Q4 2016.